
    
      54 cirrhotic patients with uppre-gastrointestinal bleeding were entrolled and were
      distributed into terlipressin group and control group at 1:1 rate. Patients in Terlipressin
      group received 1mg/6h of terlipressin intravenously for 5 days, and patients in control group
      recerved 1mg/12h of Somatostatin intravenously for 5 days.

      At enrollment, 24h,48h,72,and 1week, the renal function index level( serum creatinine,urine
      biochemistry and Urinary tubule injury index etc) were tested.
    
  